These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18518793)

  • 1. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
    Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate.
    Selg E; Ewing P; Acevedo F; Sjöberg CO; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):181-9. PubMed ID: 23094685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering horseradish peroxidase as a respirable powder to the isolated, perfused, and ventilated lung of the rat: the pulmonary disposition of an inhaled model biopharmaceutical.
    Selg E; Acevedo F; Nybom R; Blomgren B; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):273-84. PubMed ID: 20455769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.
    Borgström L; Bondesson E; Morén F; Trofast E; Newman SP
    Eur Respir J; 1994 Jan; 7(1):69-73. PubMed ID: 8143834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler.
    Andrade-Lima M; Pereira LF; Fernandes AL
    J Bras Pneumol; 2012; 38(6):748-56. PubMed ID: 23288120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler.
    Chrystyn H; Safioti G; Keegstra JR; Gopalan G
    Int J Pharm; 2015 Aug; 491(1-2):268-76. PubMed ID: 26043823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol.
    Grekas N; Athanassiou K; Papataxiarchou K; Rizea Savu S; Silvestro L
    J Pharm Pharmacol; 2014 Dec; 66(12):1677-85. PubMed ID: 25109416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
    Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of budesonide plus formoterol (BF) Spiromax® and BF Turbohaler® (with and without charcoal block) in healthy volunteers.
    Weisfeld L; Shu Y; Shah TP
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):593-602. PubMed ID: 26042485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
    Chambers F; Ludzik A
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel method to aerosolize powder for short inhalation exposures at high concentrations: isolated rat lungs exposed to respirable diesel soot.
    Gerde P; Ewing P; Låstbom L; Ryrfeldt A; Waher J; Lidén G
    Inhal Toxicol; 2004 Jan; 16(1):45-52. PubMed ID: 14744664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
    Jeppsson AB; Nilsson E; Waldeck B
    Eur J Pharmacol; 1994 May; 257(1-2):137-43. PubMed ID: 8082695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant Function.
    Sørli JB; Da Silva E; Bäckman P; Levin M; Thomsen BL; Koponen IK; Larsen ST
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):306-11. PubMed ID: 26524226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.
    Nikander K; Turpeinen M; Wollmer P
    J Aerosol Med; 1999; 12(2):47-53. PubMed ID: 10539706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 22024920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults.
    Eklund A; Tronde A; Johannes-Hellberg I; Gillen M; Borgström L
    Biopharm Drug Dispos; 2008 Oct; 29(7):382-95. PubMed ID: 18623040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats.
    Jones RM; Harrison A
    Xenobiotica; 2012 Jan; 42(1):75-85. PubMed ID: 22077102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.